Galapagos NV Corporation
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Funding Status:
Public Company
Industry:
Pharma
Estimated Revenue:
$100M to $500M
Technology:
Biopharma, Biotechnology, Clinical Trials, Medical
Acquisitions Number:
5.0
Headquarters:
Mechelen-bovelingen, Limburg, Belgium
Total Funding:
5400000000
Last Funding Type:
Post-IPO Equity
Employee Number:
251-500
Founded Date:
1999